VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC
Aktie · US92532F1003 · VRTX · 882807 (XNAS)
Übersicht Finanzkennzahlen
450,50 USD
0,90 % 4,01 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:40

Aktuelle Kurse von VERTEX PHARMACEUTICALS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
VRTX
USD
06.06.2025 20:40
450,50 USD
443,82 USD
+1,51 %
XETR: XETRA
XETRA
VX1.DE
EUR
06.06.2025 15:35
393,10 EUR
389,55 EUR
+0,91 %
XLON: London
London
0QZU.L
USD
06.06.2025 15:14
448,32 USD
443,82 USD
+1,01 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 1,91 % 0,10 % -7,25 % -2,87 % -6,88 % 69,56 %

Firmenprofil zu VERTEX PHARMACEUTICALS INC Aktie

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Investierte Fonds

Folgende Fonds haben in investiert: VERTEX PHARMACEUTICALS INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
1.695,46
Anteil (%)
3,98 %
Fonds
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. in Mio
1.478,90
Anteil (%)
1,14 %
Fonds
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF EUR Hedged (Acc)
Vol. in Mio
645,34
Anteil (%)
1,14 %
Fonds
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. in Mio
19.976,49
Anteil (%)
1,14 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in Mio
1.137,69
Anteil (%)
1,10 %

Unternehmensdaten

Name VERTEX PHARMACEUTICALS INC
Firma Vertex Pharmaceuticals Incorporated
Symbol VRTX
Website https://www.vrtx.com
Heimatbörse XNAS NASDAQ
WKN 882807
ISIN US92532F1003
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Reshma Kewalramani FASN, M.D.
Marktkapitalisierung 110 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 6,1 T
Adresse 50 Northern Avenue, 02210 Boston
IPO Datum 2007-12-28

Aktien-Splits

Datum Split
24.08.2000 2:1

Ticker Symbole

Name Symbol
Frankfurt VX1.F
London 0QZU.L
NASDAQ VRTX
XETRA VX1.DE

Weitere Aktien

Investoren die VERTEX PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
ADOBE INC
ADOBE INC Aktie
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
ARCTICZYMES TECH ASA NK 1
ARCTICZYMES TECH ASA NK 1 Aktie
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Aktie
META PLATFORMS INC
META PLATFORMS INC Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NVIDIA CORP
NVIDIA CORP Aktie
PAYPAL INC
PAYPAL INC Aktie
TESLA INC
TESLA INC Aktie
TOLL BROTHERS
TOLL BROTHERS Aktie
WAYP REIT UTS
WAYP REIT UTS Aktie
ZETA GLOBAL HOLDINGS CORP CLASS A
ZETA GLOBAL HOLDINGS CORP CLASS A Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025